Congenital Bone Marrow Failure Syndromes: Clinical Trials

157 trials for Congenital Bone Marrow Failure Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

80 completed, 30 recruiting, 22 terminated, 9 active not recruiting. 72 Phase 2, 46 Phase 1, 23 Not applicable, 9 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 272Completed 40, Terminated 12, Recruiting 9, Active not recruiting 5, Unknown 3, Withdrawn 2, Not yet recruiting 1
Phase 146Completed 21, Terminated 10, Recruiting 8, Unknown 3, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1
Not applicable23Completed 13, Terminated 4, Active not recruiting 2, Recruiting 2, Withdrawn 2
Phase 39Completed 7, Recruiting 1, Unknown 1
Early Phase 11Completed 1
Phase 41Completed 1

Follow Congenital Bone Marrow Failure Syndromes: new trials by email Literature Review of Congenital Bone Marrow Failure Syndromes trials Research Report on Congenital Bone Marrow Failure Syndromes

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prenatal Transplantation for Fetuses With Fanconi Anemia
IUHSCT for FA-affected fetuses - Fanconi Anemia, Anemia, Hypoplastic, Congenital
Phase 1 / Phase 2Not yet recruitingAgnieszka Czechowicz122028-01-012026-06-16
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingNational Cancer Institute (NCI)10002026-10-272026-10-22
MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
MRIs - Fanconi Anemia
RecruitingUniversity of Minnesota802026-06-232026-07-02
FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector
Gene-modified autologous stem cells - Fanconi Anemia
Not applicableTerminatedShenzhen Geno-Immune Medical Institute102026-06-012026-08-24
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)
Mobilization Regimen - Diamond Blackfan Anemia
RecruitingNorthwell Health102026-06-012026-04-27
Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)
Quercetin - Dyskeratosis Congenita, Telomere Disease
Phase 1RecruitingChildren's Hospital Medical Center, Cincinnati122026-05-292026-09-10
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia
APR-2020 - RPS19 Deficient Diamond-Blackfan Anemia
Phase 1RecruitingApriligen, Inc.42026-04-162026-07-21
Nucleoside Therapy in Patients With Telomere Biology Disorders
deoxycytidine, deoxythymidine - Telomere Biology Disorders, Dyskeratosis Congenita
Phase 1RecruitingSuneet Agarwal362025-09-292026-08-04
A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients
Nitisinone - Hereditary Tyrosinemia, Type I
WithdrawnSwedish Orphan Biovitrum2025-09-012025-12-23
Enhancing the Clinical Management of CMF Through a National Pediatric and Adult Network Based on Biological and Genetic Data
Inherited Bone Marrow Failure Syndrome, Fanconi Anemia
RecruitingIstituto Giannina Gaslini2502025-05-292026-10-16
Corrective Exercise and Rehabilitation in Fanconi Anemia: A Case Study
Corrective exercise and rehabilitation - Fanconi Anemia
Not applicableCompletedPardis Specialized Wellness Institute12025-05-032025-08-12
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Phase 1 Dose Level 1, Phase 1 Dose Level 2, Phase 1 Dose Level 3 - Leukemia, High Risk Acute Lymphoblastic Leukemia
Phase 1 / Phase 2RecruitingChildren's Hospital of Philadelphia1002025-03-212026-04-15
Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
Fanconi Anemia
Active not recruitingNational Cancer Institute (NCI)202024-12-052026-10-02
Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Afatinib - Fanconi Anemia, Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau252024-11-082026-05-27
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Mavorixafor, Placebo - Neutropenia
Phase 3RecruitingX4 Pharmaceuticals1762024-06-062026-08-06
Prognostic Significance of Mutation Type and Chromosome Fragility in Fanconi Anemia
Fanconi Anemia
CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2272024-05-162024-07-08
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
Shwachman-Diamond Syndrome, SDS
RecruitingShwachman-Diamond Syndrome Alliance Inc80002024-02-072025-05-31
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
TruSight Oncology, imatinib - Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies
Phase 1RecruitingNational Cancer Institute (NCI)712023-12-192026-10-20
Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia
Bitopertin - Steroid-refractory Diamond-Blackfan Anemia (DBA)
Phase 1 / Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)152023-07-252026-06-30
A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia
FP-045 - Fanconi Anemia
Phase 1 / Phase 2WithdrawnForesee Pharmaceuticals Co., Ltd.2023-06-302025-03-06

Showing 20 of 157. Sign in to see all of them.

Narrower conditions

Fanconi Anemia (94)  ·  Anemia, Diamond-Blackfan (56)  ·  Anemia, Aplastic (36)  ·  Anemia, Sickle Cell (32)  ·  Thalassemia (25)  ·  Bone Marrow Failure Disorders (24)  ·  Myelodysplastic Syndromes (23)  ·  Dyskeratosis Congenita (22)  ·  Shwachman-Diamond Syndrome (21)  ·  Neutropenia, Severe Congenital, Autosomal Recessive 3 (17)  ·  Leukemia, Myeloid, Acute (14)  ·  Hemoglobinopathies (13)  ·  Leukemia (12)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (12)

Broader conditions

Bone Marrow Diseases (157)  ·  Hemic and Lymphatic Diseases (156)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (153)  ·  Hematologic Diseases (147)  ·  Genetic Diseases, Inborn (141)  ·  Anemia (135)  ·  Bone Marrow Failure Disorders (133)  ·  Anemia, Hypoplastic, Congenital (132)  ·  Nutritional and Metabolic Diseases (119)  ·  Metabolic Diseases (115)  ·  Anemia, Aplastic (105)  ·  DNA Repair-Deficiency Disorders (97)  ·  Red-Cell Aplasia, Pure (48)  ·  Anemia, Hemolytic (43)

Interventions

Cyclophosphamide (28)  ·  fludarabine phosphate (27)  ·  fludarabine (23)  ·  Antilymphocyte Serum (18)  ·  Busulfan (15)  ·  Alemtuzumab (14)  ·  Whole-Body Irradiation (14)  ·  Filgrastim (12)  ·  Granulocyte Colony-Stimulating Factor (11)  ·  Methylprednisolone (11)  ·  Cyclosporine (10)  ·  Melphalan (10)  ·  Mycophenolic Acid (10)  ·  Peripheral Blood Stem Cell Transplantation (9)  ·  Stem Cell Transplantation (8)

Sponsors

Masonic Cancer Center, University of Minnesota (12)  ·  National Heart, Lung, and Blood Institute (NHLBI) (11)  ·  Children's Hospital Medical Center, Cincinnati (8)  ·  Fred Hutchinson Cancer Center (6)  ·  National Cancer Institute (NCI) (6)  ·  University of California, San Francisco (6)  ·  Boston Children's Hospital (5)  ·  Novartis Pharmaceuticals (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  Roswell Park Cancer Institute (4)  ·  Bellicum Pharmaceuticals (3)  ·  Emory University (3)  ·  Fairview University Medical Center (3)  ·  Memorial Sloan Kettering Cancer Center (3)  ·  Northwell Health (3)

Countries

United States (121)  ·  Spain (12)  ·  United Kingdom (10)  ·  Italy (9)  ·  Germany (7)  ·  Australia (6)  ·  France (6)  ·  Belgium (5)  ·  China (5)  ·  Egypt (4)  ·  Greece (4)  ·  Thailand (4)  ·  Turkey (Türkiye) (4)  ·  Canada (3)  ·  Netherlands (3)

Top investigators

Adrianna Vlachos, MD (3)  ·  Farid Boulad, MD (3)  ·  Hans-Peter Kiem (3)  ·  Margaret MacMillan, MD (3)  ·  Parinda Mehta, MD (3)  ·  Paul Szabolcs, MD (3)  ·  Sharon A Savage, M.D. (3)  ·  Daniel J. Weisdorf (2)  ·  David J Young, M.D. (2)  ·  Diane George, MD (2)  ·  Elliott Vichinsky, MD (2)  ·  George Chen (2)  ·  Grover C. Bagby, MD (2)

Results publications

PMID 25824692, PMID 39642902, PMID 18723429, PMID 19951979, PMID 19996412, PMID 20383216, PMID 20566896, PMID 21071497, PMID 23585526, PMID 24296492, PMID 24370862, PMID 24385534, PMID 24786393, PMID 25304614, PMID 25345697, PMID 25405500, PMID 25425683, PMID 25459642, PMID 25691036, PMID 25963299, PMID 26095669, PMID 27537786, PMID 28280134, PMID 28684371, PMID 30047424, PMID 31151984, PMID 31501599, PMID 31836590, PMID 32015000, PMID 32634238, PMID 32750127, PMID 32790018, PMID 33025707, PMID 33159275, PMID 33810313, PMID 34086408, PMID 34162668, PMID 34485595, PMID 34665631, PMID 34751952, PMID 34852175, PMID 34857525, PMID 35322185, PMID 35360980, PMID 35500223, PMID 35726608, PMID 36378548, PMID 37120671, PMID 37142543, PMID 37354000

NIH funding

P30CA015704 (3), R01HL081499 (3), 2004 (2), R01DK057778 (2), 2014 (1), 2023 (1), P01HL048546 (1), P30CA016672 (1), P30CA069533 (1), U10HL069294 (1)